LCN2 and abdominal aortic aneurysm: In Tarín et al., LCN2−/− mice or mice treated with LCN2 antibodies showed a decreased incidence of abdominal aortic aneurysm and reduced aortic expansion compared with that of WT mice or mice treated with IgG (control), respectively [15].